Sunday March 24, 2019

Intake of Coffee can Reduce the risk of Death for Kidney Patients

Drinking Coffee may increase the lifespan of patients with chronic kidney disease.

0
//
Drinking Coffee reduces mortality in Kidney patients
Drinking Coffee reduces mortality in Kidney patients. Pixabay
  • Want to live longer? Charge up on your cup of coffee. According to a study, caffeine consumption may prolong the lifespan of patients with chronic kidney disease (CKD).

Drinking coffee can Reduce mortality 

The findings showed a dose-dependent inverse association between caffeine and all-cause mortality.

People who had the highest intake of coffee had 24 percent lower risks of dying, while those in the second, third quartile of caffeine consumption had 12 percent and 22 percent lower risk.

“These results suggest that advising patients with CKD to drink more caffeine may reduce their mortality. This would represent a simple, clinically beneficial, and inexpensive option,” said Miguel Bigotte Vieira from Centro Hospitalar Lisboa Norte, in Portugal.

However, “this benefit should ideally be confirmed in a randomised clinical trial”, Vieira added.

For the study, the team examined the association of caffeine consumption with mortality among 2328 patients with CKD. The results will be presented at the ongoing ASN Kidney Week 2017 in New Orleans.

Moreover, this observational study cannot prove that drinking coffee reduces the risk of death in patients with CKD, but only suggests the possibility of such a protective effect, Vieira stressed.

Drinking coffee can also reduce diabetes risk, revealed a reported in the American Chemical Society Journal of Natural Products.(IANS)

Next Story

Cardiovascular Events Cause 58% Deaths Among Diabetics

The medicine likewise helps lower the amount of sodium in the body and reduce triglyceride levels and blood pressure

0
Diabetes
Representational image. Pixabay

Fifty-eight percent of deaths among people with type 2 diabetes are due to cardiovascular events, a leading Mexican expert has said.

“Patients who live with this disease have a greater risk of premature death or disability derived from cardiovascular events,” Hector Sanchez Mijangos, President of the Mexican Diabetes Federation, told Efe news.

The specialist said that the high glucose levels associated with diabetes damage blood vessels, resulting in problems with blood pressure and vision, joint pain and other maladies.

Data from the World Health Organization indicate that more 442 million people suffer from type 2 diabetes.

Mexico’s Health Secretariat has found that while roughly 13 million inhabitants of the Aztec nation are living with diabetes, only half of those afflicted know they have the disease.

In 2015 alone, according to Mijangos, there were more than 98,000 premature deaths in Mexico related to diabetes and the average age of those who died was 66.7 years old.

Diabetes
Representational image. Pixabay

“This is regrettable, because these people could have lived roughly another 15 years,” he said.

According to the 2012 National Health and Nutrition Survey, only 25 percent of Mexicans suffering with diabetes are managing their condition adequately.

That figure illustrates “why our greatest challenge continues to be access and adherence to treatment”, Mijangos said.

Also Read- Researchers Discover Balance of Two Enzymes That May Help Treat Pancreatic Cancer

To improve treatment options, Mexican health authorities in January issued an approval for the use of canagliflozin, a drug that helps reduce the amount of blood glucose reabsorbed by the kidneys, which in turns causes more glucose to be eliminated through urination.

“With this medicine, a person can lose 100 milligrams of glucose per day as well as about 400 kilocalories (4,000 calories) a day, which also helps with weight loss,” Mijangos said.

The medicine likewise helps lower the amount of sodium in the body and reduce triglyceride levels and blood pressure.

A scientific trial involving more than 10,000 patients worldwide showed that when combined with conventional treatment, canagliflozin can reduce the incidence of cardiovascular events by up to 18 percent. (IANS)